HEPATITIS B
Hepatitis B Virus Program
12
Universal Hepatitis B Immunization
5
Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta Viruses
8
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
12
Infection with the hepatitis B virus
5
Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
11
Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus
5
Schistosomiasis, hepatitis B and hepatitis C co infection
6
Universal Hepatitis B Vaccination Reduces Childhood Hepatitis B Virus–Associated Membranous Nephropathy
7
Hepatitis B virus infection
144
Hepatitis B or Hepatitis C and its underlying Factors
6
Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers
8
TREATMENT OF CHRONIC HEPATITIS B, DELTA RELATED LIVER DISEASE AND NON-A NON-B HEPATITIS
7
Hepatitis B Virus Core Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection
6
Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients
12
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
7
Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen.
5
HEPATITIS B INFECTION IN GREENLAND
11
Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection
5
Original Article Beta2-Glycoprotein I in Hepatitis B virus infection patients with hepatocellular carcinoma, chronic hepatitis B and acute hepatitis B
7